NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF

NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF

Benzopyran compounds with strong anti-estrogenic activity and essentially no estrogenic activity are provided, which are OP-1038, which is 3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol, and OP-1074, which is (2S)-3-(4-hydroxyphenyl)-4-methyl-2-(4-{...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MYLES, DAVID, C. DC, GALLAGHER, LESLIE, CAROL HODGES LCH, KUSHNER, PETER, J. PJ, HARMON, CYRUS, L. CL
Format: Patent
Sprache:chi ; eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MYLES, DAVID, C. DC
GALLAGHER, LESLIE, CAROL HODGES LCH
KUSHNER, PETER, J. PJ
HARMON, CYRUS, L. CL
description Benzopyran compounds with strong anti-estrogenic activity and essentially no estrogenic activity are provided, which are OP-1038, which is 3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol, and OP-1074, which is (2S)-3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol. OP-1074 is a pure anti-estrogen when tested in the agonist mode and a complete anti-estrogen when tested in the antagonist mode. These compounds are useful for the treatment or prevention of a variety of conditions that are modulated through the estrogen receptor in mammals including humans.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HK1199246A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HK1199246A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HK1199246A13</originalsourceid><addsrcrecordid>eNrjZLD08w9z9VFwcvWL8g-IDHL0U3D29w3wD_VzCdaBMIM9Qzz9_YIVHP1cFEKDXYMVQjxcg1z93XgYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbyHt6GhpaWRiZmjoTERSgBrxSi7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF</title><source>esp@cenet</source><creator>MYLES, DAVID, C. DC ; GALLAGHER, LESLIE, CAROL HODGES LCH ; KUSHNER, PETER, J. PJ ; HARMON, CYRUS, L. CL</creator><creatorcontrib>MYLES, DAVID, C. DC ; GALLAGHER, LESLIE, CAROL HODGES LCH ; KUSHNER, PETER, J. PJ ; HARMON, CYRUS, L. CL</creatorcontrib><description>Benzopyran compounds with strong anti-estrogenic activity and essentially no estrogenic activity are provided, which are OP-1038, which is 3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol, and OP-1074, which is (2S)-3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol. OP-1074 is a pure anti-estrogen when tested in the agonist mode and a complete anti-estrogen when tested in the antagonist mode. These compounds are useful for the treatment or prevention of a variety of conditions that are modulated through the estrogen receptor in mammals including humans.</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150626&amp;DB=EPODOC&amp;CC=HK&amp;NR=1199246A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150626&amp;DB=EPODOC&amp;CC=HK&amp;NR=1199246A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MYLES, DAVID, C. DC</creatorcontrib><creatorcontrib>GALLAGHER, LESLIE, CAROL HODGES LCH</creatorcontrib><creatorcontrib>KUSHNER, PETER, J. PJ</creatorcontrib><creatorcontrib>HARMON, CYRUS, L. CL</creatorcontrib><title>NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF</title><description>Benzopyran compounds with strong anti-estrogenic activity and essentially no estrogenic activity are provided, which are OP-1038, which is 3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol, and OP-1074, which is (2S)-3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol. OP-1074 is a pure anti-estrogen when tested in the agonist mode and a complete anti-estrogen when tested in the antagonist mode. These compounds are useful for the treatment or prevention of a variety of conditions that are modulated through the estrogen receptor in mammals including humans.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD08w9z9VFwcvWL8g-IDHL0U3D29w3wD_VzCdaBMIM9Qzz9_YIVHP1cFEKDXYMVQjxcg1z93XgYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbyHt6GhpaWRiZmjoTERSgBrxSi7</recordid><startdate>20150626</startdate><enddate>20150626</enddate><creator>MYLES, DAVID, C. DC</creator><creator>GALLAGHER, LESLIE, CAROL HODGES LCH</creator><creator>KUSHNER, PETER, J. PJ</creator><creator>HARMON, CYRUS, L. CL</creator><scope>EVB</scope></search><sort><creationdate>20150626</creationdate><title>NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF</title><author>MYLES, DAVID, C. DC ; GALLAGHER, LESLIE, CAROL HODGES LCH ; KUSHNER, PETER, J. PJ ; HARMON, CYRUS, L. CL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HK1199246A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>MYLES, DAVID, C. DC</creatorcontrib><creatorcontrib>GALLAGHER, LESLIE, CAROL HODGES LCH</creatorcontrib><creatorcontrib>KUSHNER, PETER, J. PJ</creatorcontrib><creatorcontrib>HARMON, CYRUS, L. CL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MYLES, DAVID, C. DC</au><au>GALLAGHER, LESLIE, CAROL HODGES LCH</au><au>KUSHNER, PETER, J. PJ</au><au>HARMON, CYRUS, L. CL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF</title><date>2015-06-26</date><risdate>2015</risdate><abstract>Benzopyran compounds with strong anti-estrogenic activity and essentially no estrogenic activity are provided, which are OP-1038, which is 3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol, and OP-1074, which is (2S)-3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol. OP-1074 is a pure anti-estrogen when tested in the agonist mode and a complete anti-estrogen when tested in the antagonist mode. These compounds are useful for the treatment or prevention of a variety of conditions that are modulated through the estrogen receptor in mammals including humans.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_HK1199246A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T11%3A43%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MYLES,%20DAVID,%20C.%20DC&rft.date=2015-06-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHK1199246A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true